Form D · Biotechnology

Bone Solutions Inc

Dallas, TX · CIK 0001335451

Offering snapshot reported Jun 19, 2015 · SEC filing

Reported sold
$215K
Indefinite offering
Investors reported
10
Form D · investor count
Minimum accepted
$10K
Reported outside-investor minimum
First sale
Dec 5, 2013
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$108K$215KDec 20, 2013: $40,000.00Dec 20, 2013Jun 19, 2015: $215,000.00Jun 19, 2015

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$40,000 → $215,000
  • Reported investors2 → 10

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jun 19, 2015Amendment$215,000$175,000vs Dec 20, 201310SEC filing
Dec 20, 2013Initial$40,000No comparison2SEC filing
Dec 30, 2011AmendmentYet to sellNo comparison31SEC filing
Aug 4, 2005PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Equity, Option to acquire, Security to be acquired
Exemptions
06c
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$500K (estimated)
Form D file number
021-208448

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Tess JackovichNone
The De Angelis GroupNone

Source: Form D, filed Jun 19, 2015. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Emanual Anthony Copp Director, Executive
E. Anthony Copp Director, Executive
Drew M Diaz Director, Executive
Wade B Hampton Director
Philip D Holcombe Director
Thomas Lally Director, Executive
James A Mc Namara Director, Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
10,000 N Central Expressway Suite 900
Dallas, TX, 75231